Related Experiment Video
Updated: Jun 26, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
Laparoscopic pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy
Saud Al-Shanafey1, Zakaria Habib, Saleh AlNassar
1Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia. saud132@hotmail.com
Insights
Laparoscopic pancreatectomy is a feasible and safe surgical option for infants with persistent hyperinsulinemic hypoglycemia (PHHI) unresponsive to medication. Further long-term studies are needed to confirm its effectiveness.
Area of Science:
- Pediatric Surgery
- Endocrinology
- Minimally Invasive Surgery
Background:
- Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is the leading cause of persistent neonatal hypoglycemia.
- Medical management is the first line of treatment, with surgery reserved for refractory cases.
- Laparoscopic pancreatectomy is an emerging alternative to traditional open surgery for PHHI.
Purpose of the Study:
- To evaluate the feasibility and safety of laparoscopic pancreatectomy for PHHI.
- To report surgical outcomes and patient follow-up data for this procedure.
Main Methods:
- Retrospective chart review of 12 patients with PHHI undergoing laparoscopic pancreatectomy between March 2004 and February 2008.
- Data collected included demographics, clinical information, extent of pancreatectomy, and postoperative outcomes.
- Statistical analysis was performed using SPSS version 10.
Main Results:
- Twelve patients underwent laparoscopic pancreatectomy, with a median age of 11.5 months.
- Median pancreatectomy extent was 90%; 16% required conversion to open surgery.
- 33% achieved euglycemia without medication; others required medical management (octreotide, diazoxide) postoperatively. One patient experienced recurrent hypoglycemia and another developed diabetes post-reoperation.
Conclusions:
- Laparoscopic pancreatectomy appears feasible and safe for medically unresponsive PHHI.
- Longer follow-up is necessary to fully establish the long-term effectiveness of this surgical approach.
Background:
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is considered the most common cause of persistent neonatal hypoglycemia. Management of PHHI involves use of medical agents and its failure is an indication of surgical intervention. Traditionally, an open pancreatectomy was the standard of care but recently laparoscopic pancreatectomy was described. We report our experience with laparoscopic pancreatectomy for PHHI for the period from March 2004 to February 2008.
Methods:
A retrospective chart review was conducted for patients managed for PHHI with laparoscopic pancreatectomy for that period. Demographic and clinical data were retrieved. Descriptive data were generated, and SPSS version 10 statistical package (SPSS, Chicago, Ill) was used.
Results:
Twelve patients diagnosed with PHHI were managed with laparoscopic pancreatectomy for that period. Median age at procedure was 11.5 months (range, 0.5-89 months). Median extent of pancreatectomy was 90% (range, 85%-95%). There were 2 (16%) conversions to open technique. One patient (8%) required reoperation 3 months after the procedure. Patients were followed up for a median of 23.5 months (range, 3-48 months). Four (33%) were euglycemic with no medications. Three patients remained on octreotide postoperatively to be euglycemic, and 3 patients needed a combination of octreotide and diazoxide. One patient remained euglycemic for 10 months then started on octreotide because of recurrence of hypoglycemia. One patient remained hypoglycemic postoperatively and required reoperation 3 months later to control symptoms. He became diabetic 4 months after reoperation on insulin.
Conclusions:
Our data suggest that laparoscopic pancreatectomy for medically unresponsive PHHI is feasible and safe. Longer follow-up is needed to ascertain effectiveness.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
